Document
Human Subjects Determination
ICR 201809-0920-008 · OMB 0920-0920 · Object 87173201.
⚠️ Notice: This form may be outdated. More recent filings and information on OMB 0920-0920 can be found here:
Document [pdf]
Download: pdf | txt
12/18/2015 REQUEST FOR NCHHSTP PROJECT DETERMINATION & APPROVAL NCHHSTP ADS/ADLS Office on behalf of CDC (New, Continuation, or Amendment) This form should be used to request NCHHSTP/OD/ADS or ADLS office review and approval on behalf of CDC of a new, continued, or amended project for those projects for which NCHHSTP staff/employees, branches, divisions, and center/OD/ADS or ADLS office are responsible. Any NCHHSTP activity that meets the definition of a project (see the following section) and represents one of the four project categories must be approved by the respective NCHHSTP branch and division and by the NCHHSTP/OD/ADS or ADLS office. Approval by the NCHHSTP ADS or ADLS office (nchstphs@cdc.gov) of these projects indicates approval by CDC. This review and approval process complies with obligations for adherence of projects to federal regulations, state laws, ethics guidelines, CDC policies, and publication requirements. For research that involves identifiable human subjects in which CDC/NCHHSTP is engaged, use CDC Human Research Protection Office forms and submit them to CDC Human Research Protection Office through the NCHHSTP ADS human subjects email box after approval at the branch and division levels. RELEVANT INFORMATION What is a project? A project is defined as a time-limited activity that is funded for a specific period of time, an activity with specified funds for a limited time, or as a limited time responsibility by specific CDC employees or staff, including projects that might be ongoing or continuous for an extended period. A project has defined objectives, tasks (e.g., essential public health services), dedicated resources, and is funded for a specified time. NCHHSTP reviews and approves projects for the four project categories listed on this form. Every project officer, project team and staff, NCHHSTP branch, and NCHHSTP division or office is responsible for submitting this form for each project and for obtaining NCHHSTP OD/ADS or ADLS approval on behalf of CDC before project initiation, continuation, or amendment. Such programs as surveillance are approved and funded as specific projects for certain periods. What is research? The federal regulations and CDC/OD/ADS office define research as a systematic investigation, including research development, testing and evaluation, designed to develop or contribute to generalizable knowledge. Activities that meet this definition constitute research, regardless if these activities are conducted or supported under a program that is not considered research for other purposes. For example, demonstration and service programs sometimes include research activities. What is a human subject? A human subject is a living individual about whom an investigator (whether professional or student) conducting research obtains 1. data through intervention or interaction with the individual or 2. identifiable private information. What is an intervention? Intervention includes both physical procedures by which data are gathered (e.g., venipuncture) and manipulations of the subject or the subject's environment that are performed for research purposes. Interaction includes communication or interpersonal contact between investigator and subject. Page 1 of 12 12/18/2015 What is private information? Private information includes information about behavior that occurs in a context in which an individual can reasonably expect that no observation or recording is occurring and information that has been provided for specific purposes by an individual and that the individual can reasonably expect will not be made public (e.g., a medical record). Private information identifies individuals (i.e., the identity of the person is or might be readily ascertained by the investigator or associated with the information) for the information to constitute research involving human subjects. What does being “engaged” mean? An institution becomes “engaged" in human subjects research when its employees or agents intervene or interact with living individuals for research purposes, or obtains individually identifiable private information for research purposes. An institution is automatically considered to be engaged in human subjects research whenever it receives funding or resources (e.g., a direct award) to support such research. In such cases, the awardee institution has the ultimate responsibility for protecting human subjects under the award. What is surveillance? CDC defines surveillance as “the ongoing, systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice, closely integrated with the timely dissemination of these data to those who need to know. The final link of the surveillance chain is the application of these data to prevention and control. A surveillance system includes a functional capacity for data collection, analysis, and dissemination linked to public health programs.” What is program evaluation? Program evaluation is the systematic collection of information about the activities, characteristics, and outcomes of programs to make judgments about the program, improve program effectiveness, or inform or guide decisions about future program development. Program evaluation should not be confused with treatment efficacy, which measures how well a treatment achieves its goals and that can be considered research. Sources (links) http://intranet.cdc.gov/od/oads/osi/hrpo/ http://www.hhs.gov/ohrp/index.html Page 2 of 12 Project Title: Data Collection Through Web Based Surveys for Evaluating Act Against AIDS Social Marketing Campaign Phases Ta 12/18/2015 PROJECT REQUEST Project Stage Choose one by selecting a checkbox: New: Fill out entire form, even if a protocol is attached (approval is for work by CDC/NCHHSTP employees). ■ Continuation: For projects expected to continue beyond NCHHSTP approved date; include brief description of changes and attach clean and marked copies of approved determination (approval is for continued work by CDC/NCHHSTP employees). Amendment: Include brief description of changes and attach relevant documentation and a copy of approved project (approval is for continued work by CDC/NCHHSTP employees). Project Information: Project Title: Data Collection Through Web Based Surveys for Evaluating Act Against AIDS Social Marketing Campaign Phases Ta NCHHSTP Project Number: PN - 0128 (IRB Online #6184) Division: Division of HIV/AIDS Prevention (DHAP) Project Location/Country(ies): Multiple U.S. cities Telephone: (404) 639-8297 CDC Project Officer or CDC Co-Leads: Euna August Project Dates: Start 05/01/2018 End 04/30/2022 Laboratory Branch Submission: If applicable, select the checkbox: Project Categories Select the corresponding checkbox to choose the category and subcategory. ■ I. Activity is not human subject research. The primary intent of the project is public health practice or a disease control activity. A. Epidemic or endemic disease control activity; collected data directly relate to disease control. If this project is an Epi-AID; provide the Epi-AID number and documentation of the request for assistance, per division policy. Epi-AID no. B. Routine disease surveillance activity; data will be used for disease control program or policy purposes. ■ C. Program evaluation activity; data will be used primarily for that purpose. D. Post-marketing surveillance of effectiveness or adverse effects of a new regimen, drug, vaccine, or device. E. Laboratory proficiency testing. Page 3 of 12 Project Title: Data Collection Through Web Based Surveys for Evaluating Act Against AIDS Social Marketing Campaign Phases Ta 12/18/2015 II. Activity is not human subjects research. The primary intent is public health program activities. A. Public health program activity (e.g., service delivery; health education programs; social marketing campaigns; program monitoring; electronic database construction or support; development of patient registries; needs assessments; and demonstration projects to assess organizational needs, management, and human resource requirements for implementation). B. Activity is purely administrative (e.g., purchase orders or contracts for services or equipment). III. Activity is research but does NOT involve identifiable human subjects. A. Activity is research involving collection or analysis of data about health facilities or other organizations or units (i.e., not individual persons.) B. Activity is research involving data or specimens from deceased persons. C. Activity is research using unlinked or anonymous data or specimens: ALL (1–4) below are required: 1. No one has contact with human subjects in this project; and 2. Data or specimens are or were collected for another purpose; and 3. No extra data or specimens are or were collected for this project; and 4. Identifying information was (one of the following boxes must be checked) a. not obtained; b. removed before this submission, or before CDC receipt, so that data cannot be linked or re-linked with identifiable human subjects; or c. protected through an agreement (i.e., CDC investigators and the holder of the key linking the data to identifiable human subjects enter into an agreement prohibiting the release of the key to the investigators under any circumstances. A copy of the agreement must be attached.) IV. Activity is research involving human subjects, but CDC involvement does not constitute “engagement in human subject research.” Select only one option by checking the box: A indicates the project has current funding; B or C indicates no current funding is applicable. A. This project is funded under a grant, cooperative agreement, or contract award mechanism. ALL of the following 3 elements are required: 1. CDC staff will not intervene or interact with living individuals for research purposes. 2. CDC staff will not obtain individually identifiable private information. 3. Supported institution(s) must have a Federalwide Assurance (FWA), and the project must be reviewed and approved by a registered IRB or an institutional office linked to the supported institution’s FWA.* Supported institution of primary investigator or co-Investigators/entity name:* Page 4 of 12 Project Title: Data Collection Through Web Based Surveys for Evaluating Act Against AIDS Social Marketing Campaign Phases T 12/18/2015 Supported institution/entity FWA Number:* FWA expiration date:* Expiration date of IRB approval:* *Attach copy of IRB approval letter(s) supporting project review and approval. B. CDC staff provide technical support that does not involve possession or analysis of data or interaction with participants from whom data are being collected (no current CDC funding). C. CDC staff are involved only in manuscript writing for a project that has closed. For the project, CDC staff did not interact with participants and were not involved with data collection (no current CDC funding). Page 5 of 12 Project Title: Data Collection Through Web Based Surveys for Evaluating Act Against AIDS Social Marketing Campaign Phases Ta 12/18/2015 Project Description Participating project staff must complete all 18 elements of this section. This is a required description from CDC employees or staff for review and approval of a project plan or proposal (or for changes) for projects conducted by CDC or in which CDC is involved. All 18 elements are required to standardize the review and approval process across NCHHSTP, document that all 18 elements have been addressed, expedite review and approval by the NCHHSTP ADS or ADLS office, and minimize CDC/OD/ADS office audit requests for additional information. A protocol may be attached to this form, but it does not eliminate the requirement to complete all 18 elements. PROJECT TITLE: Data Collection Through Web Based Surveys for Evaluating Act Against AIDS Social Marketing Campaign Phases T Instructions: Use the following boxes to complete the 18 items. Each box will expand as you type, and you are not limited in the length of your answers. Formatting features and symbols also may be used. 1. CDC Principal Investigator(s) or Project Directors and branch/division/office affiliations: Euna M. August, PhD, MPH, MCHES, Division of HIV/AIDS Prevention (DHAP), Prevention Communications Branch (PCB) 2. CDC Project Officer(s) and each person’s role and responsibilities and affiliations: Euna August, PhD, MCHES, (DHAP/PCB) will be working as the Technical Monitor on the project. Dr. August will be responsible for overseeing each individual data collection and daily management of the project. 3. Other CDC project members, branches, divisions, and other participating institutions, partners, and staff: DHAP/PCB: A range of staff from the the PCB may serve as project members on individual data collection projects under this PD. These may include: Tiffiany Aholou, PhD, MSW, Elana Morris, MPH, Dayna Alexander, DrPH, MSPH, MCHES, Jocelyn Taylor, MPH, Ann Ussery-Hall, MPH, CHES RTI International: A range of staff from CDC's evaluation contractor may serve as project members for individual data collection projects including: Jennifer Uhrig, PhD, Vanessa Boudewyns, PhD, Jennie Harris, MPH, and Monica Scales, PhD 4. Institution(s) or other entity(ies) funding the project: No other entities are funding the project. Page 6 of 12 Project Title: Data Collection Through Web Based Surveys for Evaluating Act Against AIDS Social Marketing Campaign Phases T 12/18/2015 5. Project goals: The goal is to evaluate the effectiveness of AAA campaign phases and messages aimed at increasing HIV/AIDS awareness, increasing prevention behaviors, and improving HIV testing rates among consumers. Evaluation findings will be used for ongoing improvement of the AAA campaign. 6. Project objectives: The main objectives are to examine receptivity to messages and perceived credibility among populations exposed to AAA phases and messages; differences in attitudes, beliefs, and knowledge about HIV among those who report exposure and do not report exposure to AAA phases and messages; intentions related to HIV prevention; and behaviors among those who report and do not report exposure to the various AAA messages. 7. Public health (program or research) needs to be addressed: Information obtained through this project will be used to improve campaign messages by informing CDC and its stakeholders about the potential effects of campaign messages among the targeted sample, identifying how campaign messages should be modified. Information gained will also be used to support the ongoing evaluation of the AAA campaign. The data from the proposed evaluation may be used to assess the appropriateness of continued or expanded funding and dissemination of the campaign. 8. Population(s) or groups to be included: Adults aged 18 to 64 from cities across the United States will be included in this project. Based on the target audience for the campaign phase or messages, we will oversample subpopulations disproportionately affected by HIV, such as people living with HIV (PLWH), gay and bisexual men (MSM), transgender people, Blacks/African Americans, Hispanics/Latinos, young adults (aged 18 to 29 years), and people who inject drugs (PWID). 9. Project methods: Evaluation data will be conducted via 30-minute closed-ended, online surveys with up to 2,148 individuals annually. The recruitment method will vary depending on the nature of the campaign phase or messages being evaluated (see item #10 for specific methods). Potential participants will be recruited through online survey panel vendors, external partners (e.g., community-based organizations, membership organizations), and the Internet. Individuals will be screened for eligibility using a standardized screening form. If eligible, individuals will be invited to participate. Participants will self-administer the survey at home on their personal computer or devices. Page 7 of 12 Project Title: Data Collection Through Web Based Surveys for Evaluating Act Against AIDS Social Marketing Campaign Phases T 12/18/2015 10. Selection, inclusion, or sampling of participants (persons or entities): We will employ non-probability purposive sampling to recruit participants from cities across the United States. The samples for the surveys will consist of participants selected from a combination of sources, including (1) online survey vendors with proprietary panel lists, (2) external partners (e.g., community-based or membership organizations), and (3) the Internet. Inclusion criteria will depend on the specific AAA phase being evaluated and the target population for the messaging. The informed consent process and screener will be combined. Participants who consent will complete the screener, and if eligible, they will be linked to the online survey. 11. Incentives to be provided to participants: Participants will be offered a token of appreciation of $20-$40 cash or cash equivalent for taking part in a survey; higher amounts will be offered for data collections involving specific audiences known to be difficult to reach (e.g., MSM, PLWH). By providing monetary incentives, we can improve coverage of specialized respondents, rare groups, or minority populations, including MSM, transgender men and women, African Americans, and Hispanics. Including these respondents is important to this study to improve the generalizability of findings and ensure that the campaign materials reflect the information needs and perspectives of those at highest risk for HIV. 12. Plans for data collection and analysis: The web-based surveys will be self-administered and accessible any time of day for a designated period. All data collection materials are at an 8th grade reading level or below due to sample eligibility criteria and CDC requirements. Each respondent can complete the survey only once. Data from completed surveys will then be compiled into an SPSS (Statistical Package for the Social Sciences) dataset by the survey vendor and sent to the evaluation contractor for analysis, with no information in identifiable form (IIF). Descriptive statistics (frequencies, means, and standard deviations) will be calculated. Additionally, a variety of statistical analyses, including independent samples t-tests, chi-square tests, and one-way analysis of variance, will be conducted to identify any statistically significant, group-level differences. 13. Confidentiality protections: RTI, CDC's evaluation contractor, maintains restricted access to all data preparation areas (i.e., receipt and coding). All data files on multi-user systems will be under the control of a database manager, with access limited to project staff on a “need-to-know” basis only. The online vendor panels take the following security measures to ensure separation between participants’ identity and their survey data. First, the survey instrument does not contain PII. The only way a survey is identified is with a digital identification number. Second, although the invitation method (i.e., e-mail, mail, or direct mail) will inherently have PII information included, this will not be combined with survey responses so the responses from the survey cannot be linked to the PII. Third, screener data will be considered part of the survey data. The vendors will provide the results of the screener questions for all panelists, regardless of whether they qualify for the study. However, they will not retain responses to screening questions for those who are deemed ineligible for any other purpose outside the scope of this project. Fourth, the vendors will retain study records for the duration of the study. Upon final delivery of data files to RTI and completion of the project, the vendors will destroy all study records, including data files, upon request. The vendors will not be able to supply or access this information for any reason, even at the request of RTI, once destroyed. Finally, data coming directly from the survey engine are stored in a proprietary database. Although these data are not encrypted, once inside the firewall, they are stored in a relational database protected by several layers of intrusion detection and access control. Data files delivered to RTI by the vendors will be sent via encrypted files. CDC will not be provided with PII. 14. Other ethics concerns (e.g., incentives, risks, privacy, or security): Individuals may be uncomfortable answering questions related to sexual orientation or behavior, HIV status, or substance use. However, participants are told that they can skip any question that makes them feel uncomfortable. In addition, it is possible that someone else (e.g., family member, friend) could view the survey on the participant’s computer with or without his/her knowledge, which could lead to conflict or cause discomfort. The consent form suggests that participants take the survey in a private location and reminds them to close their browser window when they are finished taking the survey. 15. Projected time frame for the project: The projected time frame is 5/1/2018 to 4/30/2022, depending on the OMB approval process. Page 8 of 12 Project Title: Data Collection Through Web Based Surveys for Evaluating Act Against AIDS Social Marketing Campaign Phases T 12/18/2015 16. Plans for publication and dissemination of the project findings: Data collected will be analyzed and incorporated into written evaluation report(s). The findings may also be published in peer-reviewed journal articles and/or presented at scientific conferences. 17. Appendices — including informed consent documents, scripts, data collection instruments, focus group guides, fact sheets, or brochures: See attached documents: Attachment 3: Potential Survey Items Attachment 4: Sample Participant Consent Form Attachment 5: Sample Email Invitation and Reminder for Non-Responders Attachment 6: Sample Study Screener Attachment 7: Identification of and Justification for Sensitive Questions 18. References (to indicate need and rationale for project): Page 9 of 12 Project Title: Data Collection Through Web Based Surveys for Evaluating Act Against AIDS Social Marketing Campaign Phases Ta 12/18/2015 PROJECT APPROVAL Choose one of the following options (Division or Center/OD Project) DIVISION PROJECT NCHHSTP BRANCH AND DIVISION ADS REVIEW AND APPROVAL (Sign electronically by clicking next to the X and following the prompts) X Jo E. Stryker S Digitally signed by Jo E. Stryker -S Date: 2018.04.02 08:32:02 -04'00' Branch Chief or Branch Science Officer X signed by Laura J. Laura J. Fehrs Digitally Fehrs -S Date: 2018.04.16 12:46:48 -S -04'00' Division ADS, Acting ADS, or Deputy ADS CENTER/OD PROJECT NCHHSTP OD OFFICE REVIEWS AND APPROVALS (Sign electronically by clicking next to the X and following the prompts) X X Office Associate Director or Designee NCHHSTP ADS or Designee Page 10 of 12 Project Title: Data Collection Through Web Based Surveys for Evaluating Act Against AIDS Social Marketing Campaign Phases Ta 12/18/2015 NCHHSTP ADS/DEPUTY ADS OR ADLS REVIEW AND APPROVAL Project Title: Data Collection Through Web Based Surveys for Evaluating Act Against AIDS Social Marketing Campaign Phases T Date received in NCHHSTP ADS or ADLS office: Date received by NCHHSTP Deputy ADS or ADLS: Select the checkbox for each applicable comment for Nos. 1–5 or select the checkbox for No. 6 if all of the comments apply. Additional applicable comments may be added to No. 7. If additional information is required before approval can be granted, select No. 8. 1. This project is approved by NCHHSTP/CDC and CDC (per CDC policies and federal regulations) for CDC staff participation. 2. Participating partners and sites must obtain project review and approval, according to their institutional policies and procedures and according to local, national, and international regulations and laws, including 45 CFR 46 regulations and state laws. CDC project officers must maintain a current copy of local sites’ approvals in project records. 3. CDC investigators and project officers need to adhere to the highest ethics standards of conduct and to respect and protect the privacy, confidentiality, autonomy, data, welfare, and rights of participants and integrity of the project. All applicable country, state, and federal laws and regulations must be followed. 4. Informed consent or script is needed as required by laws and regulations. Information conveyed in an informed consent or script process needs to address all applicable required elements of informed consent. Consent of employees in related projects about their institutions needs to include a statement that their voluntary participation or withdrawal would not affect their employment status or opportunities. 5. OMB Paperwork Reduction Act determination by the NCHHSTP OMB/PRA Coordinator might be needed for this project. ■ 6. All previous comments apply. 7. Other applicable comments: Type your comment in the box. The space will expand as you type. 8. More information is required before approval is granted: Explain what additional information is requested by typing in the box. The space will expand as you type. Date Information was requested: Date Information was received: Page 11 of 12 12/18/2015 Approval must be granted by the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Associate Director for Science (ADS), Acting ADS, or Deputy ADS, or for laboratory-associated projects, by the Associate Director for Laboratory Science (ADLS) or Acting ADLS. Project Title: Data Collection Through Web Based Surveys for Evaluating Act Against AIDS Social Marketing Campaign Phases Ta X Alcia A. Williams -S6 Digitally signed by Alcia A. Williams -S6 Date: 2018.04.17 12:47:41 -04'00' X NCHHSTP ADS, Acting ADS, or Deputy ADS NCHHSTP ADLS or Designee Or Page 12 of 12
| File Type | application/pdf |
| File Title | NCHHSTP-Determination-Applicability-Human-Subjects-Regulations |
| Subject | CDC, Centers for Disease Control and Prevention, Coordinating Center for Infectious Diseases, CCID, ADS, Associate Director for |
| Author | HHS/CDC/NCHHSTP |
| File Modified | 2018-04-17 |
| File Created | 2016-01-07 |